EWING, N.J.--(BUSINESS WIRE)--BioLeap, Inc., a drug design company that leverages its proprietary technology platform to conceive structurally-diverse, target-specific chemical entities, today announced that Dr. Gene Cordes has joined its Board of Directors.
